ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago

Human Genetics

Volumn 111, Issue 4-5, 2002, Pages 398-400

  Shea, Patrick R ^a   Ferrell, Robert E ^a   Patrick, Alan L ^b   Kuller, Lewis H ^a   Bunker, Clareann H ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b Tobago Regional Health Authority   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; DNA; DNA HOMOLOG; LEUCINE; NUCLEOTIDE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CARIBBEAN ISLANDS; CONTROLLED STUDY; DNA FLANKING REGION; EXON; GENE; GENE FREQUENCY; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HISTOLOGY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TATA BOX; TRINIDAD AND TOBAGO;

ADULT; AGED; BASE SEQUENCE; DNA PRIMERS; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; TRINIDAD AND TOBAGO;

EID: 0036820941     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-002-0816-1     Document Type: Article

References (11)

1. Bouchardy C, Mirra AP, Khlat M, Parkin DM, DeSouza JM, Gotlieb SL (1991) Ethnicity and cancer risk in Sao Paulo, Brazil. Cancer Epidemiol Biomarkers Prev 1:21-27
2. Bunker CH, Patrick AL, Konety BR, Dhir R, Brufsky AM, Vivas CA, Becich MJ, Trump DL, Kuller LH (2002) High prevalence of screening-detected prostate cancer among Afro-Caribbeans: The Tobago prostate cancer survey. Cancer Epidemiol Biomarkers Prev 11:726-729
3. Glover FE Jr, Coffey DS, Douglas LL, Cadogan M, Russell H, Tulloch T, Baker TD, Wan RL, Walsh PC (1998) The epidemiology of prostate cancer in Jamaicans. J Urol 159:1984-1986
4. Platz EA, Rimm EB, Willett WC, Kantoff PW, Giovannucci E (2000) Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Nat Cancer Inst 92:2009-2017
5. Rebbeck TR, Walker AH, Zeigler-Johnson C, Weisburg S, Martin AM, Nathanson KL, Wein AJ, Malkowicz SB (2000) Association of HPC2/ELAC2 genotypes and prostate cancer. Am J Hum Genet 67:1014-1019
6. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clogg L, Edwards BK (eds) (2000) SEER Cancer Statistics Review, 1973-1997 National Cancer Institute, Bethesda, Maryland
7. Silverberg E, Lubera JA (1989) Cancer statitics, 1989. CA Cancer J Clin 39:3-20
8. Suarez BK, Gerhard DS, Lin J, Haberer B, Nguyen L, Kesterson NK, Catalona WJ (2001) Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls. Cancer Res 61:4982-4984
9. Tavtigian SV, Simard J, Teng DHF, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, et al. (2001) A candidate prostate susceptibility gene at chromosome 17p. Nat Genet 27:172-180
10. Vesprini D, Nam RK, Trachtenberg J, Jewett MAS, Tavtigian SV, Emami M, Ho M, Toi A, Narod SA (2001) HPC2 variants and screening-detected prostate cancer. Am J Hum Genet 68:912-917
11. Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Carhan JR, Blute ML, Schaid DJ, Thibodeau SN (2001) Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer Res 61:6494-6499